Syndax Pharmaceuticals' stock price moved following changes in earnings estimates, prompting institutional investors to calculate fair value.
1 report, 1 independent
Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Syndax Pharmaceuticals' stock price moved following changes in earnings estimates, prompting institutional investors to calculate fair value.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Syndax Pharmaceuticals
business
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksAll You Need to Know About Syndax (SNDX) Rating Upgrade to Buy Syndax Pharmaceuticals (SNDX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating chang